NeurogesX Inc 4
Accession 0001012975-07-000255
Filed
May 8, 8:00 PM ET
Accepted
May 9, 3:33 PM ET
Size
48.0 KB
Accession
0001012975-07-000255
Insider Transaction Report
- Conversion
Series A Convertible Preferred Stock
2007-05-07−27,312→ 0 total→ Common Stock (1,820 underlying) - Conversion
Common Stock
2007-05-07+11,004→ 11,004 total - Conversion
Series C Convertible Preferred Stock
2007-05-07−2,339,915→ 0 total→ Common Stock (155,994 underlying) - Conversion
Series C Convertible Preferred Stock
2007-05-07−56,900→ 0 total→ Common Stock (3,793 underlying) - Conversion
Series A Convertible Preferred Stock
2007-05-07−4,772,668→ 0 total→ Common Stock (318,177 underlying) - Conversion
Series B Convertible Preferred Stock
2007-05-07−30,347→ 0 total→ Common Stock (2,023 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−7,497,552→ 0 total→ Common Stock (499,839 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−1,876,992→ 0 total→ Common Stock (125,132 underlying) - Conversion
Common Stock
2007-05-07+1,834,421→ 2,061,421 total - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−50,520→ 0 total→ Common Stock (3,368 underlying) - Conversion
Series B Convertible Preferred Stock
2007-05-07−2,666,667→ 0 total→ Common Stock (177,777 underlying) - Conversion
Common Stock
2007-05-07+458,903→ 458,903 total - Conversion
Series C Convertible Preferred Stock
2007-05-07−9,943,100→ 0 total→ Common Stock (662,873 underlying) - Conversion
Series B Convertible Preferred Stock
2007-05-07−5,302,986→ 0 total→ Common Stock (353,532 underlying)
- Conversion
Series B Convertible Preferred Stock
2007-05-07−30,347→ 0 total→ Common Stock (2,023 underlying) - Conversion
Common Stock
2007-05-07+458,903→ 458,903 total - Conversion
Series C Convertible Preferred Stock
2007-05-07−2,339,915→ 0 total→ Common Stock (155,994 underlying) - Conversion
Series C Convertible Preferred Stock
2007-05-07−56,900→ 0 total→ Common Stock (3,793 underlying) - Conversion
Series A Convertible Preferred Stock
2007-05-07−27,312→ 0 total→ Common Stock (1,820 underlying) - Conversion
Common Stock
2007-05-07+11,004→ 11,004 total - Conversion
Series C Convertible Preferred Stock
2007-05-07−9,943,100→ 0 total→ Common Stock (662,873 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−1,876,992→ 0 total→ Common Stock (125,132 underlying) - Conversion
Series B Convertible Preferred Stock
2007-05-07−2,666,667→ 0 total→ Common Stock (177,777 underlying) - Conversion
Common Stock
2007-05-07+1,834,421→ 2,061,421 total - Conversion
Series B Convertible Preferred Stock
2007-05-07−5,302,986→ 0 total→ Common Stock (353,532 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−7,497,552→ 0 total→ Common Stock (499,839 underlying) - Conversion
Series A Convertible Preferred Stock
2007-05-07−4,772,668→ 0 total→ Common Stock (318,177 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−50,520→ 0 total→ Common Stock (3,368 underlying)
- Conversion
Series C Convertible Preferred Stock
2007-05-07−9,943,100→ 0 total→ Common Stock (662,873 underlying) - Conversion
Series A Convertible Preferred Stock
2007-05-07−27,312→ 0 total→ Common Stock (1,820 underlying) - Conversion
Common Stock
2007-05-07+458,903→ 458,903 total - Conversion
Series C Convertible Preferred Stock
2007-05-07−56,900→ 0 total→ Common Stock (3,793 underlying) - Conversion
Common Stock
2007-05-07+1,834,421→ 2,061,421 total - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−50,520→ 0 total→ Common Stock (3,368 underlying) - Conversion
Common Stock
2007-05-07+11,004→ 11,004 total - Conversion
Series B Convertible Preferred Stock
2007-05-07−30,347→ 0 total→ Common Stock (2,023 underlying) - Conversion
Series C Convertible Preferred Stock
2007-05-07−2,339,915→ 0 total→ Common Stock (155,994 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−7,497,552→ 0 total→ Common Stock (499,839 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−1,876,992→ 0 total→ Common Stock (125,132 underlying) - Conversion
Series B Convertible Preferred Stock
2007-05-07−5,302,986→ 0 total→ Common Stock (353,532 underlying) - Conversion
Series A Convertible Preferred Stock
2007-05-07−4,772,668→ 0 total→ Common Stock (318,177 underlying) - Conversion
Series B Convertible Preferred Stock
2007-05-07−2,666,667→ 0 total→ Common Stock (177,777 underlying)
- Conversion
Series C2 Convertible Preferred Stock
2007-05-07−50,520→ 0 total→ Common Stock (3,368 underlying) - Conversion
Series A Convertible Preferred Stock
2007-05-07−4,772,668→ 0 total→ Common Stock (318,177 underlying) - Conversion
Common Stock
2007-05-07+11,004→ 11,004 total - Conversion
Series B Convertible Preferred Stock
2007-05-07−5,302,986→ 0 total→ Common Stock (353,532 underlying) - Conversion
Series A Convertible Preferred Stock
2007-05-07−27,312→ 0 total→ Common Stock (1,820 underlying) - Conversion
Series C Convertible Preferred Stock
2007-05-07−9,943,100→ 0 total→ Common Stock (662,873 underlying) - Conversion
Series C Convertible Preferred Stock
2007-05-07−2,339,915→ 0 total→ Common Stock (155,994 underlying) - Conversion
Common Stock
2007-05-07+458,903→ 458,903 total - Conversion
Series C Convertible Preferred Stock
2007-05-07−56,900→ 0 total→ Common Stock (3,793 underlying) - Conversion
Series B Convertible Preferred Stock
2007-05-07−30,347→ 0 total→ Common Stock (2,023 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−1,876,992→ 0 total→ Common Stock (125,132 underlying) - Conversion
Common Stock
2007-05-07+1,834,421→ 2,061,421 total - Conversion
Series B Convertible Preferred Stock
2007-05-07−2,666,667→ 0 total→ Common Stock (177,777 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−7,497,552→ 0 total→ Common Stock (499,839 underlying)
- Conversion
Series C Convertible Preferred Stock
2007-05-07−2,339,915→ 0 total→ Common Stock (155,994 underlying) - Conversion
Common Stock
2007-05-07+1,834,421→ 2,061,421 total - Conversion
Series A Convertible Preferred Stock
2007-05-07−27,312→ 0 total→ Common Stock (1,820 underlying) - Conversion
Common Stock
2007-05-07+458,903→ 458,903 total - Conversion
Series B Convertible Preferred Stock
2007-05-07−5,302,986→ 0 total→ Common Stock (353,532 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−50,520→ 0 total→ Common Stock (3,368 underlying) - Conversion
Series B Convertible Preferred Stock
2007-05-07−2,666,667→ 0 total→ Common Stock (177,777 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−1,876,992→ 0 total→ Common Stock (125,132 underlying) - Conversion
Common Stock
2007-05-07+11,004→ 11,004 total - Conversion
Series C Convertible Preferred Stock
2007-05-07−56,900→ 0 total→ Common Stock (3,793 underlying) - Conversion
Series B Convertible Preferred Stock
2007-05-07−30,347→ 0 total→ Common Stock (2,023 underlying) - Conversion
Series A Convertible Preferred Stock
2007-05-07−4,772,668→ 0 total→ Common Stock (318,177 underlying) - Conversion
Series C Convertible Preferred Stock
2007-05-07−9,943,100→ 0 total→ Common Stock (662,873 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−7,497,552→ 0 total→ Common Stock (499,839 underlying)
- Conversion
Common Stock
2007-05-07+458,903→ 458,903 total - Conversion
Series A Convertible Preferred Stock
2007-05-07−4,772,668→ 0 total→ Common Stock (318,177 underlying) - Conversion
Series B Convertible Preferred Stock
2007-05-07−2,666,667→ 0 total→ Common Stock (177,777 underlying) - Conversion
Series C Convertible Preferred Stock
2007-05-07−2,339,915→ 0 total→ Common Stock (155,994 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−1,876,992→ 0 total→ Common Stock (125,132 underlying) - Conversion
Series B Convertible Preferred Stock
2007-05-07−30,347→ 0 total→ Common Stock (2,023 underlying) - Conversion
Series C Convertible Preferred Stock
2007-05-07−56,900→ 0 total→ Common Stock (3,793 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−50,520→ 0 total→ Common Stock (3,368 underlying) - Conversion
Common Stock
2007-05-07+11,004→ 11,004 total - Conversion
Series B Convertible Preferred Stock
2007-05-07−5,302,986→ 0 total→ Common Stock (353,532 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−7,497,552→ 0 total→ Common Stock (499,839 underlying) - Conversion
Common Stock
2007-05-07+1,834,421→ 2,061,421 total - Conversion
Series A Convertible Preferred Stock
2007-05-07−27,312→ 0 total→ Common Stock (1,820 underlying) - Conversion
Series C Convertible Preferred Stock
2007-05-07−9,943,100→ 0 total→ Common Stock (662,873 underlying)
- Conversion
Common Stock
2007-05-07+11,004→ 11,004 total - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−50,520→ 0 total→ Common Stock (3,368 underlying) - Conversion
Series B Convertible Preferred Stock
2007-05-07−5,302,986→ 0 total→ Common Stock (353,532 underlying) - Conversion
Common Stock
2007-05-07+1,834,421→ 2,061,421 total - Conversion
Series A Convertible Preferred Stock
2007-05-07−4,772,668→ 0 total→ Common Stock (318,177 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−7,497,552→ 0 total→ Common Stock (499,839 underlying) - Conversion
Series B Convertible Preferred Stock
2007-05-07−30,347→ 0 total→ Common Stock (2,023 underlying) - Conversion
Series B Convertible Preferred Stock
2007-05-07−2,666,667→ 0 total→ Common Stock (177,777 underlying) - Conversion
Series C Convertible Preferred Stock
2007-05-07−2,339,915→ 0 total→ Common Stock (155,994 underlying) - Conversion
Series A Convertible Preferred Stock
2007-05-07−27,312→ 0 total→ Common Stock (1,820 underlying) - Conversion
Common Stock
2007-05-07+458,903→ 458,903 total - Conversion
Series C Convertible Preferred Stock
2007-05-07−9,943,100→ 0 total→ Common Stock (662,873 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−1,876,992→ 0 total→ Common Stock (125,132 underlying) - Conversion
Series C Convertible Preferred Stock
2007-05-07−56,900→ 0 total→ Common Stock (3,793 underlying)
- Conversion
Series B Convertible Preferred Stock
2007-05-07−2,666,667→ 0 total→ Common Stock (177,777 underlying) - Conversion
Series A Convertible Preferred Stock
2007-05-07−27,312→ 0 total→ Common Stock (1,820 underlying) - Conversion
Common Stock
2007-05-07+458,903→ 458,903 total - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−7,497,552→ 0 total→ Common Stock (499,839 underlying) - Conversion
Common Stock
2007-05-07+11,004→ 11,004 total - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−1,876,992→ 0 total→ Common Stock (125,132 underlying) - Conversion
Common Stock
2007-05-07+1,834,421→ 2,061,421 total - Conversion
Series B Convertible Preferred Stock
2007-05-07−5,302,986→ 0 total→ Common Stock (353,532 underlying) - Conversion
Series C Convertible Preferred Stock
2007-05-07−9,943,100→ 0 total→ Common Stock (662,873 underlying) - Conversion
Series C Convertible Preferred Stock
2007-05-07−2,339,915→ 0 total→ Common Stock (155,994 underlying) - Conversion
Series A Convertible Preferred Stock
2007-05-07−4,772,668→ 0 total→ Common Stock (318,177 underlying) - Conversion
Series B Convertible Preferred Stock
2007-05-07−30,347→ 0 total→ Common Stock (2,023 underlying) - Conversion
Series C2 Convertible Preferred Stock
2007-05-07−50,520→ 0 total→ Common Stock (3,368 underlying) - Conversion
Series C Convertible Preferred Stock
2007-05-07−56,900→ 0 total→ Common Stock (3,793 underlying)
Footnotes (13)
- [F1]The number of shares of Common Stock reported in column 4 reflects a 1-for-15 reverse stock split of NeurogesX, Inc. ("NeurogesX") Common Stock, effective upon the closing of the initial public offering of NeurogesX and at which time each share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock and Series C2 Convertible Preferred Stock converted into one-fifteenth of a share of common stock.
- [F10]These securities are preferred stock and did not have an expiration date. These securities automatically converted into shares of NeurogesX Common Stock upon the May 7, 2007 closing of NeurogesX's initial public offering.
- [F11]Upon the closing of the initial public offering of NeurogesX, each share of Series B Convertible Preferred Stock automatically converted into one-fifteenth of a share Common Stock for no consideration.
- [F12]Upon the closing of the initial public offering of NeurogesX, each share of Series C Convertible Preferred Stock automatically converted into one-fifteenth of a share Common Stock for no consideration.
- [F13]Upon the closing of the initial public offering of NeurogesX, each share of Series C2 Convertible Preferred Stock automatically converted into one-fifteenth of a share Common Stock for no consideration.
- [F2]Securities held of record by ARCH Venture Fund V, L.P. ("ARCH V"). ARCH Venture Partners V, L.P. (the "GPLP"), as the sole general partner of ARCH V, may be deemed to beneficially own certain of the shares held of record by ARCH V. The GPLP disclaims beneficial ownership of all shares held of record by ARCH V in which the GPLP does not have an actual pecuniary interest. ARCH Venture Partners V, LLC (the "GPLLC"), as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by ARCH V. The GPLLC disclaims beneficial ownership of all shares held of record by ARCH V in which it does not have an actual pecuniary interest.
- [F3]Each of Messrs. Crandell, Bybee and Lazarus, as individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by ARCH V. Each of Messrs. Crandell, Bybee and Lazarus disclaims beneficial ownership of all shares held of record by ARCH V in which he does not have an actual pecuniary interest.
- [F4]Securities held of record by ARCH V Entrepreneurs Fund, L.P. ("Entrepreneurs"). The GPLP, as the sole general partner of Entrepreneurs, may be deemed to beneficially own certain of the shares held of record by Entrepreneurs. The GPLP disclaims beneficial ownership of all shares held of record by Entrepreneurs in which the GPLP does not have an actual pecuniary interest. The GPLLC, as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by Entrepreneurs. The GPLLC disclaims beneficial ownership of all shares held of record by Entrepreneurs in which it does not have an actual pecuniary interest.
- [F5]Each of Messrs. Crandell, Bybee and Lazarus, as individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by Entrepreneurs. Each of Messrs. Crandell, Bybee and Lazarus disclaims beneficial ownership of all shares held of record by Entrepreneurs in which he does not have an actual pecuniary interest.
- [F6]Securities held of record by Healthcare Focus Fund, L.P. ("Healthcare"). The GPLP, as the sole general partner of Healthcare, may be deemed to beneficially own certain of the shares held of record by Healthcare. The GPLP disclaims beneficial ownership of all shares held of record by Healthcare in which the GPLP does not have an actual pecuniary interest. The GPLLC, as the sole general partner of the GPLP, may be deemed to beneficially own certain of the shares held of record by Healthcare. The GPLLC disclaims beneficial ownership of all shares held of record by Healthcare in which it does not have an actual pecuniary interest.
- [F7]Each of Messrs. Crandell, Bybee and Lazarus, as individual Managing Directors of the GPLLC, may be deemed to beneficially own certain of the shares held of record by Healthcare. Each of Messrs. Crandell, Bybee and Lazarus disclaims beneficial ownership of all shares held of record by Healthcare in which he does not have an actual pecuniary interest.
- [F8]Upon the closing of the initial public offering of NuerogesX, each share of Series A Convertible Preferred Stock automatically converted into one-fifteenth of a share Common Stock for no consideration.
- [F9]These securities were convertible at any time into Common Stock of NeurogesX.
Documents
Issuer
NeurogesX Inc
CIK 0001385830
Related Parties
1- filerCIK 0001385830
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 3:33 PM ET
- Size
- 48.0 KB